90 Startups
  • Sector
  • Participated in
  • Year of participation

DualTpharma

  • 2012
  • Other
  • Therapeutics
A new class of dual drugs for cancer treatment which are well tolerated and can be taken orally

EdgeLeap

  • 2013
  • Enabling Technology
  • Venture Challenge
EdgeLeap is an information technology company pushing AI to its limits to surface business relevant insights from continuous stream of world’s information, helping their clients can make intelligent strategic decisions every day.

Encare Biotech

  • 2010
  • 2011
  • Other
  • Therapeutics
  • Venture Challenge
Firbornectin-EDA Monoclonal antibody for the prevention of chronic heart failure

Exbiome

  • 2015
  • Diagnostics
  • Venture Challenge
Simple blood tests to detect cancer

Exovectory

  • 2018
  • Enabling Technology
  • Therapeutics
  • Venture Challenge
Optimal delivery to ensure effective treatment of cancer and more

Gen-X

  • 2016
  • Enabling Technology
  • Venture Challenge
Next-generation gene promoters for more stable and higher recombinant protein expression.

GlycoCheck

  • 2010
  • Diagnostics
  • Other
GlycoCheck measures and analyzes microvascular health, and objectively reports a MicroVascular Health Score (MVHS)

Goal-3

  • 2019
  • Diagnostics
  • Venture Challenge
A robust patient monitoring device which is highly reliable and easy to use to prevent children in low and middle income countries unnecessary dying from severe bacterial infections.

HELIA Biomonitoring

  • 2018
  • Medical Device
  • Venture Challenge
HELIA Biomonitoring’s mission is to enable continuous monitoring of therapeutic drug concentrations, organ function markers, and treatment response markers for personalized patient care.

Hubrecht Organoid Technology (The HUB)

  • 2010
  • Enabling Technology
  • Other
the HUB provides access to a unique and robust platform that links patient-specific genetic and phenotypic information to preclinical and clinical drug-responsiveness.